IPOs

Equillium Plans IPO to Fund Clinical Trials for Transplant Drug
Xconomy
Fri, 09/21/18 - 11:02 pm
Equillium
IPOs
organ transplants
Y-mAbs raises $96M in upsized IPO
BioCentury
Fri, 09/21/18 - 12:12 am
Y-mAbs
IPOs
SpineEx registers $17m IPO
Mass Device
Thu, 09/20/18 - 11:40 am
devices
SpineEx
IPOs
spinal cage
Elanco’s $1.7 billion IPO looks too pricey, and here’s why
Marketwatch
Thu, 09/20/18 - 09:49 am
Elanco
Eli Lilly
IPOs
animal health
spinoffs
Immuno-Oncology Players Gritstone And Sutro Join The Biotech IPO Frenzy
Forbes
Wed, 09/19/18 - 11:31 am
biotech
IPOs
immuno-oncology
Gritstone Oncology
Sutro BioPharma
Principia jumps after $106.3M IPO
BioCentury
Fri, 09/14/18 - 11:39 pm
Principia Biopharma
IPOs
Allogene Therapeutics Announces Filing For IPO
CP Wire
Fri, 09/14/18 - 09:39 am
Allogene
IPOs
CAR-T
Is Moderna prepping for biotech's biggest-ever IPO?
Fierce Biotech
Thu, 09/13/18 - 11:17 pm
Moderna Therapeutics
IPOs
messenger RNA
Biotech IPOs are booming, but is the frenzy almost over?
San Francisco Chronicle, CA
Thu, 09/13/18 - 12:02 pm
biotech
IPOs
With anti-VEGF challenger in clinic, Kodiak files for IPO
BioCentury
Mon, 09/10/18 - 12:19 am
Kodiak Sciences
anti-VEGF
IPOs
Two more Peninsula IPOs tell the story of biotech's investment boom
Bizjournals.com
Sat, 09/8/18 - 11:43 pm
IPOs
Guardant Health
Kodiak Sciences
Liquid biopsy company Guardant files for NASDAQ IPO
BioCentury
Thu, 09/6/18 - 07:25 pm
IPOs
Guardant Health
liquid biopsy
Working with Patients and a Fresh $80M, Fulcrum Eyes a 2019 IPO
Xconomy
Wed, 09/5/18 - 09:30 am
Fulcrum Therapeutics
IPOs
FSHD
Principia Sets IPO Terms as It Eyes Late-Stage Studies for Lead Drug
Xconomy
Tue, 09/4/18 - 11:06 pm
Principia Biopharma
IPOs
Sutro Biopharma, Arvinas Are Latest to Tee Up Biotech IPOs
Xconomy
Thu, 08/30/18 - 11:46 pm
biotech
IPOs
Sutro BioPharma
Arvinas
cancer
The booming Boston/Cambridge biotech hub claims an industry-leading role — nobody beats it at raising record amounts of money
Endpoints
Wed, 08/29/18 - 11:07 pm
biotech
IPOs
Boston
Second time lucky? Alzheon tries for much-reduced IPO
Fierce Biotech
Tue, 08/28/18 - 10:33 am
Alzheon
IPOs
Alzheimer's disease
tramiprosate
Y-mAbs Plans IPO to Advance Two Pediatric Cancer Drugs to the FDA
Xconomy
Tue, 08/28/18 - 10:20 am
Y-mAbs
IPOs
pediatric cancer
FDA
neuroblastoma
AbbVie, Sanofi-backed Principia offers an $86M IPO after burning through $148M for pipeline work
Endpoints
Mon, 08/20/18 - 10:11 am
IPOs
Principia Biopharma
Sanofi
AbbVie
PRN1008
autoimmune disease
AstraZeneca spinout Entasis files for $86M IPO to fund antibiotic phase 3
Fierce Biotech
Mon, 08/20/18 - 10:09 am
Entasis
IPOs
AstraZeneca
clinical trials
beta-lactams

Pages